POLE and neoplasm: In order to increase the accuracy of the impact from POLE mutations and minimize the interference of hypermutated status on patient prognosis, we excluded hypermutated phenotypes (more than 500 mutations per sample) and found that the total tumor mutational burden decreased significantly.